- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01544816
Evaluating the Effects of Snack Products on Energy
May 6, 2013 updated by: Mondelēz International, Inc.
To determine the effect of snack products varying in composition, on energy in healthy adult subjects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
49
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30341
- Mercer University Center for Clinical Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The subject must provide informed consent.
- The subject is male or female, and between the ages of 20 and 45, inclusive.
- The subject is a routine, moderate daily user of caffeine (approximately 1-4 cups of coffee or equivalent).
- The subject is fluent in English.
- The subject has a minimum of a high school diploma.
- Females of Child-bearing Potential (FOCP) must have a negative urine or serum beta HCG pregnancy test at screening. FOCP must abstain from sexual activity that could result in a pregnancy, or use acceptable contraceptives throughout the period of study treatment exposure. Acceptable contraceptives include IUDs, hormonal contraceptives (oral, implanted or injectable) and double barrier methods (such as condom or diaphragm with spermicidal gel). If hormonal contraceptives are used, the period of use must be sufficiently long to achieve pharmacological effectiveness prior to study treatment exposure (refer to individual product information for details on onset of effectiveness). FOCP who are not currently sexually active, must agree to use acceptable contraception, as defined above, if they decide to become sexually active during the period of study treatment exposure .
- The subject is in good physical and mental health based on a general medical history.
- The subject has adequate visual and auditory acuity and cognitive ability to complete the assessments and is capable of understanding and following instructions for the performance tests within the normal, age-adjusted range (within one SD) at screening.
- Must be able and willing to obtain a minimum of 7 hours of sleep the night prior to each study visit.
- The subject is willing and able to comply with all requirements defined within this protocol.
- The subject reports having a snack at least two afternoons per week.
- The subject reports experiencing an "afternoon slump".
Exclusion Criteria
- The subject has a current Axis I or Axis II comorbid psychiatric diagnosis or other symptomatic manifestations that, in the opinion of the examining physician (Investigator), will contraindicate treatment with caffeine.
- Attention Deficit Disorder or Attention Deficit Hyperactivity Disorder
- BMI ≤ 19 or ≥ 30 kg/m2.
- The subject has documented allergies, adverse reactions, or intolerance to caffeine.
- The subject has any significant medical illness or condition for which caffeine is contraindicated.
- The subject has a history of drug dependence or substance use disorder based upon DSM-IV-TR criteria (excluding nicotine).
- The subject has a positive urine drug or alcohol drug test result (to include nicotine).
- The subject has participated in an investigational study or received an investigational drug within the past 28 days.
- The subject has used nicotine products within 30 days of screening or during the duration of the study.
- The subject is taking medications, that have CNS effects or affect performance, (such as sedating antihistamines and decongestant sympathomimetics, either oral or topical), and may interfere with efficacy or safety assessments.
- The subject has a concurrent chronic or acute illness (such as allergic rhinitis or severe cold), disability, or other condition that might confound the results of rating tests administered in the study or that might increase risk to the subject. Similarly, the subject will be excluded if he or she has any additional conditions that, in the Investigator's opinion, would preclude the subject from completing the study or would not be in the best interest of the subject. This would include any significant illness or unstable medical condition that could lead to difficulty complying with the protocol.
- The female subject is pregnant or lactating or planning on becoming pregnant during the study
- Hypertension or other chronic medical conditions
- Individuals who do not maintain a routine nighttime sleep schedule (e.g. no shift work).
- Individuals judged by the Investigator to be unsuitable for enrollment in this study for any reason.
- The subject has been diagnosed with phenylketonuria.
- Inability to perform performance tests within the Normal range (i.e., performance no lower than 1SD below the mean) at screening.
- The subject has a pre-existing medical condition.
- Subject has been diagnosed with a sleeping disorder.
- Subject has a fasting glucose of >110 mg/dl.
- Subject has an allergy to wheat, soy, nuts or other food.
- Subject has Kosher or Halal dietary restrictions.
- Subject reports never eating biscuits, cookies or crackers.
- Epworth Sleepiness Scale ≥ at screening (i.e., evidence of excessive daytime sleepiness).
- Dislike of chocolate flavorings
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Control Food Product
Control food product
|
control food product
Experimental food product containing ingredient 1
Experimental food product containing ingredient 2
|
Experimental: Experimental Food Product 1
Experimental food product 1
|
control food product
Experimental food product containing ingredient 1
Experimental food product containing ingredient 2
|
Experimental: Experimental Food Product 2
Experimental food product 2
|
control food product
Experimental food product containing ingredient 1
Experimental food product containing ingredient 2
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Energy questionnaire OR Rating of perceived energy OR Subjective feeling of energy (visual analog scale)
Time Frame: 90 minutes post snack
|
90 minutes post snack
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chad VanDenBerg, Pharm.D., Mercer University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
February 24, 2012
First Submitted That Met QC Criteria
February 29, 2012
First Posted (Estimate)
March 6, 2012
Study Record Updates
Last Update Posted (Estimate)
May 8, 2013
Last Update Submitted That Met QC Criteria
May 6, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- KFG-123X-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Energy
-
Wageningen UniversityTNO; Gelderse Vallei Hospital; Bonumose, Inc.RecruitingEnergy Intake | Energy MetabolismNetherlands
-
Liverpool John Moores UniversityAlliance for Potato Research and EducationCompletedEnergy Supply; Deficiency | Energy Balance | Energy AvailabilityUnited Kingdom
-
University of South CarolinaCompleted
-
Institut National de Recherche pour l'Agriculture...Centre de Recherche en Nutrition Humaine Rhone-Alpe; Centre de Recherche en...CompletedEnergy Expenditure | Computer Simulation | Energy MetabolismFrance
-
Ori Diagnostic Instruments LLCSuspendedBody Composition | Energy Expenditure | Energy Metabolism | Body FluidsUnited States
-
David Grant U.S. Air Force Medical CenterCompletedEvaluation of Energy Drink Consumption on ECG and Hemodynamic Parameters in Young Healthy VolunteersHemodynamic Effects of Energy Drink | Electrocardiograph Effects of Energy DrinksUnited States
-
Mondelēz International, Inc.Cognitive Research CorporationCompleted
-
The Center for Applied Health Sciences, LLCCompleted
-
Radicle ScienceCompleted
-
University Hospital, Clermont-FerrandNot yet recruitingEnergy Expenditure, Appetite, Energy Intake, Food Reward Menopause TransitionFrance
Clinical Trials on Snack Product
-
Penn State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Feeding BehaviorsUnited States
-
Purdue UniversityCompleted
-
Ocean Spray Cranberries, Inc.Recruiting
-
King's College LondonNot yet recruitingDepression | AnxietyUnited Kingdom
-
King's College LondonRecruitingImmune ResponseUnited Kingdom
-
Harokopio UniversityNational and Kapodistrian University of AthensCompletedOverweight and ObesityGreece
-
Ryerson UniversityThe Hershey CompanyCompletedFood Intake | SatietyCanada
-
Mondelēz International, Inc.Reading Scientific Services Ltd.Completed
-
King's College LondonQueen Mary University of London; University of LiverpoolCompletedEating Behavior | Human MicrobiomeUnited Kingdom